28 February 2018

According to Carla van Herpen in a radio interview on NPO 1 in the context of Rare disease day.

As spokesman of the IKNL, van Herpen (theme Rare cancers) talked about the report on rare cancers that was published by IKNL.
Read more

 

Related news items


KWF grant for better selection of individuals and lung nodules in lung cancer screening

1 November 2021

The Dutch Cancer Society has awarded the consortium project ‘Multi-source data approach for Personalized Outcome Prediction in lung cancer screening’ with a grant of 1,425,000 Euro. Colin Jacobs will lead the work package on using artificial intelligence for accurate risk estimation of lung nodules.

read more

Radiation boost lowers risk of prostate cancer recurrence

21 January 2021

An additional external-beam radiation dose delivered directly to the tumor can benefit the prospects of men with non-metastatic prostate cancer, without causing additional side effects. The risk of relapse within five years for these men is smaller than for men who did not receive this boost.

read more

Cognitive behavioral therapy reduces severe fatigue in patients with advanced cancer during treatment

28 January 2020

In Annals of Oncology, RIHS researchers Hanneke Poort, Marlies Peters, Winette van der Graaf, Ria Nijhuis-van der Sanden and colleagues showed significant effects of cognitive behavioral therapy on fatigue in patients with advanced cancer during treatment with palliative intent.

read more

Drug-induced interstitial lung disease in advanced breast cancer patients receiving everolimus

22 August 2019

In Targeted Oncology, Annelieke Willemsen, Carla van Herpen and colleagues, showed that pulmonary function test with diffusion capacity of the lungs for carbon monoxide and serum biomarkers can be of aid to differentiate everolimus-related interstitial lung disease from other respiratory problems.

read more

Sarah Verhoeff wins audience award Radboud Talks Jury chose neuroscientist as overall winner

26 March 2019

The winner of the fifth edition of scientific pitch competition Radboud Talks is Suhas Vijayakumar, PhD candidate at the Faculty of Social Sciences and the Donders Institute. Research physician Sarah Verhoeff, Radboud Institute for Health Sciences, won the audience award.

read more

Publication on Salivary duct cancer in the International Journal of Cancer

28 March 2018

Eline Boon and Carla van Herpen described 177 patients with Salivary duct cancer (Rare cancers) with detailed information regarding treatment, outcomes and prognostic factors.

read more